In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries

Background: High rates of resistance to third-generation cephalosporins and carbapenems in Enterobacterales have been reported in Latin America. Ceftazidime/avibactam (CZA) is the combination of a third-generation cephalosporin and a non-β-lactam β-lactamase inhibitor, which has shown activity again...

Descripción completa

Detalles Bibliográficos
Autores principales: Appel, Tobias Manuel, Mojica, María Fernanda, De La Cadena, Elsa, Pallares, Christian José, Radice, Marcela A., Castañeda-Méndez, Paulo, Jaime-Villalón, Diego A., Gales, Ana C., Munita, José M., Villegas, María Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168198/
https://www.ncbi.nlm.nih.gov/pubmed/32033394
http://dx.doi.org/10.3390/antibiotics9020062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168198/
https://www.ncbi.nlm.nih.gov/pubmed/32033394
http://dx.doi.org/10.3390/antibiotics9020062

Ejemplares similares